FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A UC San Francisco study shows a correlation between depression and higher body temperatures, hinting at new treatment methods through
Read MoreWe’re halfway through the Medicaid “unwinding,” in which states are dropping people from the government health insurance program for the
Read MoreAccording to the United Nations, meat and dairy production would need to be doubled to meet the predicted demand for
Read MoreAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.
Read MoreStates are plowing billions of dollars into a high-stakes health care experiment that’s exploding around the country: using scarce public
Read MoreBoxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Danish drugmaker Novo
Read MoreKatheryn Houghton “IT’S BEEN REVEALED THAT FAUCI BROUGHT COVID TO THE MONTANA ONE YEAR BEFORE COVID BROKE OUT IN THE
Read MoreSACRAMENTO, Calif. — Wildfire smoke. Drought. Brutal heat. Floods. As Californians increasingly feel the health effects of climate change, state
Read MoreA pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk,
Read MoreA sign for Publicis Groupe SA is seen at their headquarters in Paris, France, on Sunday, July 28, 2013. Balint
Read More